Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
- PMID: 35246191
- PMCID: PMC8896100
- DOI: 10.1186/s13023-022-02251-7
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Abstract
Background: Neurodegeneration with brain iron accumulation describes a group of rare heterogeneous progressive neurodegenerative disorders characterized by excessive iron accumulation in the basal ganglia region. Pantothenate kinase-associated neurodegeneration (PKAN) is a major form of this disease.
Results: A total of 7 unrelated patients were diagnosed with PKAN in a single tertiary center from August 2009 to February 2018. Ten variants in PANK2 including three novel sequence variants and one large exonic deletion were detected. Sequencing of the breakpoint was performed to predict the mechanism of large deletion and AluSx3 and AluSz6 were found with approximately 97.3% sequence homology.
Conclusion: The findings support the disease-causing role of PANK2 and indicate the possibility that exonic deletion of PANK2 found in PKAN is mediated through Alu-mediated homologous recombination.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.Orphanet J Rare Dis. 2023 Apr 12;18(1):80. doi: 10.1186/s13023-023-02687-5. Orphanet J Rare Dis. 2023. PMID: 37046296 Free PMC article.
-
Exploring Yeast as a Study Model of Pantothenate Kinase-Associated Neurodegeneration and for the Identification of Therapeutic Compounds.Int J Mol Sci. 2020 Dec 30;22(1):293. doi: 10.3390/ijms22010293. Int J Mol Sci. 2020. PMID: 33396642 Free PMC article.
-
Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.J Neurol Sci. 2014 May 15;340(1-2):233-6. doi: 10.1016/j.jns.2014.03.001. Epub 2014 Mar 11. J Neurol Sci. 2014. PMID: 24655737
-
Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.Curr Opin Pediatr. 2003 Dec;15(6):572-7. doi: 10.1097/00008480-200312000-00005. Curr Opin Pediatr. 2003. PMID: 14631201 Review.
-
Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature.Neurocase. 2020 Jun;26(3):175-182. doi: 10.1080/13554794.2020.1752739. Epub 2020 Apr 20. Neurocase. 2020. PMID: 32310012 Review.
Cited by
-
Case report: Asymmetric bilateral deep brain stimulation for the treatment of pantothenate kinase-associated neurodegeneration in a patient: a unique case of atypical PKAN with a novel heterozygous PANK2 mutation.Front Hum Neurosci. 2024 Oct 16;18:1448606. doi: 10.3389/fnhum.2024.1448606. eCollection 2024. Front Hum Neurosci. 2024. PMID: 39479227 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources